ROCKET PHARMACEUTICALS INC's ticker is and the CUSIP is 77313F906. A total of 4 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,659,690 | +258.5% | 81,000 | +247.6% | 0.01% | +500.0% |
| Q2 2023 | $462,971 | +56.2% | 23,300 | +34.7% | 0.00% | 0.0% |
| Q1 2023 | $296,349 | +91.7% | 17,300 | +119.0% | 0.00% | – |
| Q4 2022 | $154,603 | -43.4% | 7,900 | -53.8% | 0.00% | -100.0% |
| Q3 2022 | $273,000 | +68.5% | 17,100 | +44.9% | 0.00% | – |
| Q2 2022 | $162,000 | +8000.0% | 11,800 | +11700.0% | 0.00% | – |
| Q4 2021 | $2,000 | -77.8% | 100 | -66.7% | 0.00% | – |
| Q3 2021 | $9,000 | -99.3% | 300 | -99.0% | 0.00% | -100.0% |
| Q2 2021 | $1,324,000 | +338.4% | 29,900 | +339.7% | 0.00% | – |
| Q1 2021 | $302,000 | -47.6% | 6,800 | -35.2% | 0.00% | -100.0% |
| Q4 2020 | $576,000 | -8.0% | 10,500 | -61.7% | 0.00% | -50.0% |
| Q3 2020 | $626,000 | +49.4% | 27,400 | +37.0% | 0.00% | 0.0% |
| Q2 2020 | $419,000 | +360.4% | 20,000 | +400.0% | 0.00% | +100.0% |
| Q4 2019 | $91,000 | +405.6% | 4,000 | +344.4% | 0.00% | – |
| Q2 2018 | $18,000 | -52.6% | 900 | -55.0% | 0.00% | – |
| Q1 2018 | $38,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 81,000 | $1,659,690 | 0.01% |
| JANE STREET GROUP, LLC | 384,200 | $7,872,258 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 28,600 | $586 | 0.00% |